Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ABVX · against 192 other Healthcare companies of similar size
Ranked #154 of 193 · scores higher than 1% of peers
Bars: peers in each 10-point band of the valuation score40 peers with a valuation score of 0–9, including ABVX · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | ABVX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 191 reported | Not reported | 2.4% | — | — | 30% |
| EBITDA yieldHigher is better · 192 reported | -4.5% | 4.5% | 10% | 50% | |
| Free cash flow yieldHigher is better · 115 reported | -2.9% | 1.2% | 22% | 20% | |
| Book yieldHigher is better · 192 reported | 6.7% | 20.5% | 17% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 151 | 4.2B USD | 30 | 41 | |
| 151 | 4.7B USD | 30 | 42 | |
| 153 | 10.1B EUR (≈$11.1B) | 29 | ||
| 154 | 3.9B USD | 8 | 47 | |
| 154 | 7.7B USD | 8 | 36 | |
| 154 | 6.9B EUR (≈$7.6B) | 8 | ||
| 154 | 4.1B USD | 8 | 39 | |
| 154 | 10.2B USD | 8 | ||
| 154 | 8.4B USD | 8 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score